Thank you to all that attended. To access a full recap of this archived meeting, please Click HERE.

BIOPHARMA CONGRESS III

November 14, 2017

Disruption In Biopharma

The Ritz-Carlton, Washington D.C.

1150 22nd Street, NW

PRESENTED BY FRIENDS OF CANCER RESEARCH + PREVISION POLICY

DRUG PRICING. APPROVAL STANDARDS. THE FUTURE FDA.

MEDICARE PART B & D. MEDICAID EXPANSION OR CONTRACTION.

2017 CONFIRMED SPEAKERS

TOM DASCHLE

JOE GROGAN (OMB)

JANET WOODCOCK (CDER)

RICHARD PAZDUR (OCE)

WILSON BRYAN (CBER)

MARK MCCLELLAN (DUKE-MARGOLIS)